L. Fiume

4.2k total citations · 1 hit paper
120 papers, 3.4k citations indexed

About

L. Fiume is a scholar working on Molecular Biology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L. Fiume has authored 120 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 25 papers in Hepatology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L. Fiume's work include Glycosylation and Glycoproteins Research (21 papers), Silymarin and Mushroom Poisoning (19 papers) and Cancer, Hypoxia, and Metabolism (16 papers). L. Fiume is often cited by papers focused on Glycosylation and Glycoproteins Research (21 papers), Silymarin and Mushroom Poisoning (19 papers) and Cancer, Hypoxia, and Metabolism (16 papers). L. Fiume collaborates with scholars based in Italy, Germany and United States. L. Fiume's co-authors include Giuseppina Di Stefano, C. Busi, A Mattioli, Heinz Faulstich, Fiorenzo Stirpe, Theodor Wieland, Marcella Manerba, Marina Vettraino, G. Barbanti‐Brodano and V. Marinozzi and has published in prestigious journals such as Nature, The Lancet and Hepatology.

In The Last Decade

L. Fiume

117 papers receiving 3.2k citations

Hit Papers

Amatoxins, Phallotoxins, Phallolysin, and Antamanide: The... 1978 2026 1994 2010 1978 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Amatoxins, Phallotoxins, Phallolysin, and Antamanide: The Biologically Active Components of PoisonousAmanitaMushroom
    1978 394 citations L. Fiume et al. profile →

Peers

L. Fiume
Balkrishen Bhat United States
Richard J. Stockert United States
Anatol G. Morell United States
Guhung Jung South Korea
Kyoichi A. Watanabe United States
David A. Ostrov United States
James A. Cardelli United States
Yuichi Yamamura Japan
Karl Y. Hostetler United States
Marie C.M. Lin Hong Kong
Balkrishen Bhat United States
L. Fiume
Citations per year, relative to L. Fiume L. Fiume (= 1×) peers Balkrishen Bhat

Countries citing papers authored by L. Fiume

Since Specialization
Citations

This map shows the geographic impact of L. Fiume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Fiume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Fiume more than expected).

Fields of papers citing papers by L. Fiume

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Fiume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Fiume. The network helps show where L. Fiume may publish in the future.

Co-authorship network of co-authors of L. Fiume

This figure shows the co-authorship network connecting the top 25 collaborators of L. Fiume. A scholar is included among the top collaborators of L. Fiume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Fiume. L. Fiume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brighenti, Elisa, Domenica Carnicelli, Maurizio Brigotti, & L. Fiume. (2017). The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis. Biochemical and Biophysical Research Communications. 485(4). 742–745. 6 indexed citations
2.
Fiume, L., Marcella Manerba, & Giuseppina Di Stefano. (2014). Albumin–drug conjugates in the treatment of hepatic disorders. Expert Opinion on Drug Delivery. 11(8). 1203–1217. 8 indexed citations
3.
Fiume, L., et al.. (2012). Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. Biochemical and Biophysical Research Communications. 430(2). 466–469. 28 indexed citations
4.
Manerba, Marcella, Marina Vettraino, L. Fiume, et al.. (2011). Galloflavin (CAS 568‐80‐9): A Novel Inhibitor of Lactate Dehydrogenase. ChemMedChem. 7(2). 311–317. 159 indexed citations
5.
Fiume, L., Marcella Manerba, Marina Vettraino, & Giuseppina Di Stefano. (2011). Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. European Journal of Pharmacology. 670(1). 39–43. 32 indexed citations
6.
Fiume, L. & Giuseppina Di Stefano. (2010). Lactosaminated human albumin, a hepatotropic carrier of drugs. European Journal of Pharmaceutical Sciences. 40(4). 253–262. 22 indexed citations
7.
Fiume, L., Michele Baglioni, C. Busi, Marcella Manerba, & Giuseppina Di Stefano. (2009). The enhancement of interstitial transport of a doxorubicin–lactosaminated albumin conjugate by imatinib: In rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow. European Journal of Pharmaceutics and Biopharmaceutics. 72(3). 630–631. 2 indexed citations
8.
Stefano, Giuseppina Di, L. Fiume, Michele Baglioni, et al.. (2006). A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade. Liver International. 26(6). 726–733. 22 indexed citations
9.
Fiume, L., Luigi Bolondi, C. Busi, et al.. (2005). Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. Journal of Hepatology. 43(4). 645–652. 43 indexed citations
10.
Stefano, Giuseppina Di, et al.. (2003). Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier. Digestive and Liver Disease. 35(6). 428–433. 27 indexed citations
11.
Stefano, Giuseppina Di, et al.. (2003). Synthesis and physicochemical characteristics of a liver‐targeted conjugate of fluorodeoxyuridine monophosphate with lactosaminated human albumin. Rapid Communications in Mass Spectrometry. 17(22). 2503–2507. 5 indexed citations
12.
Stefano, Giuseppina Di, et al.. (2002). Conjugates of Nucleoside Analogs with Lactosaminated Human Albumin to Selectively Increase the Drug Levels in Liver Blood: Requirements for a Regional Chemotherapy. Journal of Pharmacology and Experimental Therapeutics. 301(2). 638–642. 7 indexed citations
13.
Stefano, Giuseppina Di, C. Busi, & L. Fiume. (2002). Floxuridine coupling with lactosaminated human albumin to increase drug efficacy on liver micrometastases. Digestive and Liver Disease. 34(6). 439–446. 20 indexed citations
14.
Stefano, Giuseppina Di, et al.. (2001). Coupling of 5-fluoro 2′-deoxyuridine to lactosaminated poly-l-lysine: an approach to a regional, non-invasive chemotherapy of liver micrometastases. Biochemical Pharmacology. 61(4). 459–465. 4 indexed citations
15.
Stefano, Giuseppina Di & L. Fiume. (1997). Liver Glycotargeting of Antiviral Nucleoside Analogues.. Trends in Glycoscience and Glycotechnology. 9(50). 461–472. 1 indexed citations
16.
Fiume, L., Giuseppina Di Stefano, C. Busi, et al.. (1997). Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor. Journal of Viral Hepatitis. 4(6). 363–370. 33 indexed citations
17.
Fiume, L., C. Busi, Giuseppina Di Stefano, & A Mattioli. (1993). Coupling of Antiviral Nucleoside Analogs to Lactosaminated Human Albumin by Using the Imidazolides of Their Phosphoric Esters. Analytical Biochemistry. 212(2). 407–411. 18 indexed citations
18.
19.
Fiume, L., C. Busi, & A Mattioli. (1982). Lactosaminated human serum albumin as hepatotropic drug carrier. FEBS Letters. 146(1). 42–46. 30 indexed citations
20.
Fiume, L., et al.. (1970). Amantis. Chemistry and action. FEBS Letters. 8(1). 1–5. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Balkrishen Bhat Breakdown of academic impact, for papers by Richard J. Stockert Breakdown of academic impact, for papers by Anatol G. Morell Breakdown of academic impact, for papers by Guhung Jung Breakdown of academic impact, for papers by Kyoichi A. Watanabe Breakdown of academic impact, for papers by David A. Ostrov Breakdown of academic impact, for papers by James A. Cardelli Breakdown of academic impact, for papers by Yuichi Yamamura Breakdown of academic impact, for papers by Karl Y. Hostetler Breakdown of academic impact, for papers by Marie C.M. Lin
Rankless by CCL
2026